Norris Financial Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.08M	Sell	342,477 -3,535	-1%	-$51.7K	1.66%	18
2025 Q4	$5.52M	Buy	346,012 +1,142	+0.3%	+$16.2K	1.88%	12
2025 Q3	$3.81M	Sell	344,870 -4,765	-1%	-$52K	1.39%	20
2025 Q2	$2.96M	Sell	349,635 -38,208	-10%	-$306K	1.21%	28
2025 Q1	$3.12M	Sell	387,843 -20,909	-5%	-$169K	1.46%	16
2024 Q4	$3.67M	Sell	408,752 -8,762	-2%	-$71.5K	1.72%	15
2024 Q3	$3.06M	Sell	417,514 -8,887	-2%	-$55.1K	1.51%	15
2024 Q2	$2.43M	Sell	426,401 -8,433	-2%	-$44.4K	1.27%	23
2024 Q1	$2.18M	Buy	434,834 +31,510	+8%	+$214K	1.2%	24
2023 Q4	$3.63M	Sell	403,324 -6,875	-2%	-$56.6K	2.2%	12
2023 Q3	$3.19M	Buy	410,199 +3,169	+0.8%	+$31K	2.21%	12
2023 Q2	$3.94M	Buy	407,030 +3,209	+0.8%	+$33.3K	2.73%	11
2023 Q1	$4.43M	Sell	403,821 -6,019	-1%	-$53K	3.25%	9
2022 Q4	$1.77M	Sell	409,840 -10,194	-2%	-$59.1K	1.5%	20
2022 Q3	$3.16M	Buy	420,034 +8,029	+2%	+$69.5K	2.89%	12
2022 Q2	$4.14M	Buy	412,005 +22,546	+6%	+$252K	3.33%	12
2022 Q1	$4.82M	Buy	389,459 +39,310	+11%	+$608K	2.91%	14
2021 Q4	$8.01M	Buy	350,149 +51,919	+17%	+$1.23M	4.83%	4
2021 Q3	$6.6M	Buy	298,230 +17,170	+6%	+$272K	4.36%	5
2021 Q2	$3.64M	Buy	281,060 +47,123	+20%	+$600K	2.46%	15
2021 Q1	$3.04M	Buy	233,937 +141,782	+154%	+$2.06M	2.23%	17
2020 Q4	$1.27M	Buy	92,155 +2,841	+3%	+$41.3K	1%	26
2020 Q3	$1.32M	Buy	89,314 +4,727	+6%	+$68.5K	1.11%	25
2020 Q2	$1.37M	Buy	84,587 +19,301	+30%	+$309K	1.3%	18
2020 Q1	$947K	Buy	65,286 +10,758	+20%	+$190K	1.05%	25
2019 Q4	$1.1M	Buy	+54,528	New	+$502K	1.02%	24